Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q1 2018 Earnings

7MarConfirmed

Q2 2017

Q3 2017

Q4 2017

Q1 2018

-4.27

-3.7

-3.12

-2.55

Details

Expected EPS

-3.59

Actual EPS

-2.55

Surprise EPS

1.04

Surprise Percent

+28.97%

Description

Celldex Therapeutics (CLDX) has reported earnings of -2.55 per share for Q1 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.